Signova Pharma Private Limited

Signova Pharma Private Limited - pharma in Guwahati, Assam, India. FY 2026 financials & compliance.
CIN U51397AS2008PTC008558 Incorporated 04 January 2008 ROC Guwahati HQ Guwahati, Assam, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2025
₹130.91 Cr
▲ 38.45% YoY
Net profit · FY 2025
₹6.79 Cr
Net margin 5.2%
EBITDA · FY 2025
₹11.66 Cr
EBITDA margin 8.9%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹40 Lakh
Issued & subscribed
Open charges
₹34.29 Cr
Satisfied ₹21.95 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
546
Provident fund records

About Signova Pharma Private Limited

Data last updated:

Signova Pharma Private Limited is a private limited company based in Guwahati, Assam, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 January 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U51397AS2008PTC008558. Its GSTIN is 18AAMCS2756E1Z4 (Assam). The company holds 5 GST registrations, of which 4 are active.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹40 Lakh. It is led by directors Satrajit Kanungo and Ranjan Kumar Deka.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at House No – 44 Ground Floor Barthakur Mill Road Ulubari, Guwahati, Assam, India – 781007.

As per the financials filed for FY 2025, the company reported a revenue of ₹130.91 Cr. For the same year it recorded a net profit of ₹6.79 Cr (net margin 5.2%) and EBITDA of ₹11.66 Cr (EBITDA margin 8.9%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 16% over five years.

The company has about 546 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Signova Pharma. As per MCA filings, the company has open charges of ₹34.29 Cr and satisfied charges of ₹21.95 Cr on record. Court records list 7 cases involving the company, including 2 filed by the company and 5 filed against it; 3 cases are pending. The company has 4 deals on record (3 funding rounds, 1 rights issue), with disclosed funding of ₹1.03 Cr; the latest was in March 2016. Its 8 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 5 larger and 3 smaller; the largest is BLD Pharmatech (India) Private Limited with revenue of ₹137.25 Cr.

Signova Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-16-0001038). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website signovapharma.com.

Company details

CIN U51397AS2008PTC008558
Registration Number 008558
Incorporation Date 04 January 2008
ROC Guwahati
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-AS-16-0001038

Recognitions & Rankings of Signova Pharma

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-AS-16-0001038

Contact details

Signova Pharma Private Limited's registered office is in Guwahati, Assam. Its website is signovapharma.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    House No – 44 Ground Floor Barthakur Mill Road Ulubari, Guwahati, Assam, India – 781007
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Signova Pharma Private Limited, buy the company report.

Comprehensive company report
Signova Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Signova Pharma operates one associated brand: Signova Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical product development and distribution in healthcare.signovapharma.com

Business activity

The main business activity of Signova Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Signova Pharma Private Limited, buy the company report.

Financials of Signova Pharma Private Limited

FY 2024 filings available

Signova Pharma Private Limited reported revenue of ₹130.91 Cr for FY 2025.

Revenue · FY 2025
₹130.91 Cr
Net profit · FY 2025
₹6.79 Cr margin 5.2%
EBITDA · FY 2025
₹11.66 Cr margin 8.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 17%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 18%
5 years · compounded
▲ 20%

Revenue has grown at a compounded annual rate (CAGR) of 16% over five years. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹11.66 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.79 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin8.9%
Net Profit Margin5.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Signova Pharma Private Limited, buy the company report.

Board of directors of Signova Pharma Private Limited

Signova Pharma has 2 directors on record. No former directors are listed.

Current Directors

Peer comparison

Signova Pharma Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
BLD Pharmatech (India) Private Limited₹137.25 Cr (FY 2025)23.0%Hyderabad, Telangana, India
Surat Sales Pvt Ltd₹135.04 Cr (FY 2025)121.0%Surat, Gujarat, India
Organon (India) Private Limited₹134.83 Cr (FY 2025)20.0%Mumbai, Maharashtra, India
R.S. Surgipharm Private Limited₹134.47 Cr (FY 2025)32.0%Gujarat, India
Shivanitin Agencies Private Limited₹132.83 Cr (FY 2025)50.0%Dehradun, Uttarakhand, India
Signova Pharma Private Limitedthis company₹130.91 Cr (FY 2025)₹6.79 Cr5.2%546Guwahati, Assam, India
Milton Lifecare Private Limited₹130.32 Cr (FY 2024)37.0%Mumbai, Maharashtra, India
Oceanic Techno Chem Private Limited₹128.85 Cr (FY 2025)57.0%Mumbai, Maharashtra, India
Vasavi Medicare Solutions Private Limited₹128.66 Cr (FY 2025)20.0%Coimbatore, Tamil Nadu, India

To see the full peer comparison of Signova Pharma Private Limited, buy the company report.

Auditor

Signova Pharma Private Limited is audited by MANISH RAJKUMAR & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
MANISH RAJKUMAR & CO.FY 2023324945E

Shareholding

The shareholding of Signova Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Signova Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹34.29 Cr
Satisfied charges
₹21.95 Cr
Breakdown by lending institutions
Others₹34.29 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
13 Mar 2024100881535Others₹19.99 LakhOpen
15 Feb 2024100871505Others₹16.11 LakhOpen
15 Feb 2024100871788Others₹17.01 LakhOpen
27 Sep 2022100641256Others₹33.76 CrOpen
24 Nov 2021100504321Axis Bank Limited₹1.6 CrSatisfied

To see the full charge records of Signova Pharma Private Limited, buy the company report.

Total charge records: 9 View all charges

Deals & funding

Signova Pharma Private Limited has 4 deals on record (3 funding rounds, 1 rights issue), with disclosed funding of ₹1.03 Cr; the latest was in March 2016.

Total deals
4
Funding rounds
3
Rights issue
1
Disclosed funding
₹1.03 Cr

Deals on record (4 of 4)

WhenDealAmountParties
Mar 2016Rights issue₹55 LakhInvestors: an individual
Mar 2016Funding round₹55 LakhInvestors: an individual
Jan 2013Funding round₹40 LakhInvestors: 4 individuals
Sep 2009Funding round₹8 LakhInvestors: 4 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Signova Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Signova Pharma has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Associated companies

Employees & EPFO

Signova Pharma Private Limited has a workforce of 546 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
546
Active EPFO establishments
1
Employee growth
36.5%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27546
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Signova Pharma Private Limited, buy the company report.

GST

Signova Pharma has 5 GST registrations: 4 active and 1 cancelled or inactive.

Total GSTINs
5
Active
4
Cancelled / inactive
1
GSTINStateStatusRegistered on
18AAMCS2756E1Z4AssamActive01 Jul 2017
04AAMCS2756E1ZDChandigarhActive01 Jul 2017
19AAMCS2756E1Z2West BengalActive02 Aug 2019
02AAMCS2756E1ZHHimachal PradeshActive01 Sep 2021

To see the full GST registrations and return filing status of Signova Pharma Private Limited, buy the company report.

Recent activity

Signova Pharma Private Limited has 2 board changes on record since 2008: 2 appointments. The latest: Ranjan Kumar Deka was appointed as Director on 04 Jan 2008.

Charges
A charge registered on 02 Feb 2015 via Charge ID 10551372 with United Bank Of India was fully satisfied on 23 Dec 2024.
AGM
Signova Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Signova Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Guwahati.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100881535 was registered on 13 Mar 2024.
Charges
A charge with Others amounted to Rs. 0.16 Cr with Charge ID 100871505 was registered on 15 Feb 2024.
Charges
A charge with Others amounted to Rs. 0.17 Cr with Charge ID 100871788 was registered on 15 Feb 2024.
Charges
A charge with Others of Rs. 33.76 Cr registered on 27 Sep 2022 with Charge ID 100641256 was modified on 24 Jan 2024.
Charges
A charge registered on 23 Aug 2021 via Charge ID 100512541 with Hdfc Bank Limited was fully satisfied on 06 Apr 2023.
Charges
A charge registered on 24 Nov 2021 via Charge ID 100504321 with Axis Bank Limited was fully satisfied on 19 Oct 2022.
Charges
A charge with Others amounted to Rs. 33.76 Cr with Charge ID 100641256 was registered on 27 Sep 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.60 Cr with Charge ID 100504321 was registered on 24 Nov 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 9.61 Cr with Charge ID 100512541 was registered on 23 Aug 2021.

10 earlier events are in the company report.

Frequently asked questions

Signova Pharma is an active private limited company based in Guwahati, Assam, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 January 2008 (18+ years old) and is registered under CIN U51397AS2008PTC008558.

Signova Pharma has 2 current directors:

The latest financial statements of Signova Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Signova Pharma is 18AAMCS2756E1Z4, registered in Assam. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 04AAMCS2756E1ZD (Chandigarh), 19AAMCS2756E1Z2 (West Bengal), 02AAMCS2756E1ZH (Himachal Pradesh).

The CIN (Corporate Identification Number) of Signova Pharma is U51397AS2008PTC008558. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Signova Pharma has 7 court cases on record: 2 filed by the company and 5 filed against it. 3 are pending. Most are in the high courts.

Signova Pharma was incorporated on 04 January 2008, making it 18+ years old. It is registered with the Registrar of Companies, Guwahati.

Signova Pharma has 4 deals on record (3 funding rounds, 1 rights issue), with disclosed funding of ₹1.03 Cr; the latest was in March 2016.

The peers of Signova Pharma by revenue are BLD Pharmatech (India) Private Limited, Surat Sales Pvt Ltd, Organon (India) Private Limited, R.S. Surgipharm Private Limited, Shivanitin Agencies Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Ranjan Kumar Deka was appointed as Director on 04 Jan 2008. Satrajit Kanungo was appointed as Director on 04 Jan 2008.

Yes, Signova Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-AS-16-0001038).